Chronic hyperinsulinemia reduces insulin sensitivity and metabolic functions of brown adipocyte

Abstract The growing pandemics of diabetes have become a real threat to world economy. Hyperinsulinemia and insulin resistance are closely associated with the pathophysiology of Type 2 diabetes. In pretext of brown adipocytes being considered as the therapeutic strategy for the treatment of obesity and insulin resistance, we have tried to understand the effect of hyperinsulinemia on brown adipocytes function. We here with for the first time report that hyperinsulinemia induced insulin resistance in brown adipocyte is also accompanied with reduced insulin sensitivity and brown adipocyte characteristics. CI treatment decreased expression of brown adipocyte specific markers (such as PRDM16, PGC1α and UCP1) and mitochondrial content as well as activity. CI treated brown adipocyte showed drastic decrease in oxygen consumption rate (OCR) and spare respiratory capacity. Morphological study indicates increased accumulation of lipid droplets in CI treated brown adipocytes. We have further validated these findings in vivo in C57BL/6 mice implanted with mini-osmotic insulin pump for 8 weeks. CI treatment in mice lead to increased body weight gain, fat mass and impaired glucose intolerance with reduced energy expenditure and insulin sensitivity. CI treated mice showed decreased BAT characteristics and function. We also observed increased inflammation and ER stress markers in BAT of CI treated animals. The above results conclude that hyperinsulinemia have deleterious effect on brown adipocyte function, making it susceptible to insulin resistance. Thus above findings have greater implication in designing approaches for the treatment of insulin resistance and diabetes via recruitment of brown adipocytes.